INPEN MMT-105NNPKNA NOVO NORDISK PINK
Report
- Report Number
- 3012822846-2021-00845
- Event Type
- Malfunction
- Date Received
- December 1, 2021
- Date of Event
- October 19, 2021
- Report Date
- May 25, 2022
- Manufacturer
- COMPANION MEDICAL INC
- Product Code
- FMF
- UDI-DI
- 000010862088000368
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GA, US
- Reporter Occupation
- OTHER
- Health Professional
- N
Narratives
UNIT PAIRED SUCCESSFULLY TO COMMERCIAL APP. THE FOLLOWING TEST VALUES WERE DIALED AND DOSED: 4.0U, 4.0U, 4.0U, 4.0U AND 16.0U. ALL DOSED VALUES DISPLAY IN THE APP AS FOLLOW, 4.0U, 2.0U, 2.5U, 3.5U AND 8.5U. MOST VALUES DOSED WERE DISPLAYED INACCURATELY IN THE LOGBOOK. ALL DOSES WERE WRITTEN TO THE APP LOGBOOK WITHIN 1 MINUTE. THE SCREW WAS NOT BENT, ADVANCED WHEN DOSAGE KNOB WAS PRESSED DIALING A DOSAGE AND RETRACTED APPROPRIATELY. NO RESISTANCE WAS OBSERVED WHEN DOSING WITHOUT A CARTRIDGE INSTALLED. THE SCREW ADVANCED EVERY TIME 30.0U WAS DIALED AND DOSED UNTIL THE SCREW REACHED MAX EXTENSION. IN CONCLUSION: PER NETA GLASER SAN DIEGO INVESTIGATION NOTES: PLASTIC WEAR DEBRIS GOT BETWEEN THE ENCODER CONTACTS AND THE PATTERN WHEEL CAUSING SIGNAL ISSUES/MISREADING. INPEN DID PRODUCE FALSE DOSE LOGS DURING INVESTIGATION. THEREFORE, THE CUSTOMER COMPLAINT OF DOSE LOG ANOMALIES WAS CONFIRMED DUE TO DUST/DEBRIS. MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY "DEFECTS" OR HAS "MALFUNCTIONED". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT.
SERIAL NUMBER: (B)(6) . SOFTWARE VERSION: 3.8.5. COLOR: PINK. BATTERY LIFE REMAINING: <4 MONTHS. CUSTOMER REPORTS: DOSE LOG INACCURACIES. PER VISUAL INSPECTION: NO PHYSICAL DAMAGE NOTED. DEVICE PAIRED SUCCESSFULLY TO COMMERCIAL APP. THE FOLLOWING TEST VALUES WERE DIALED AND DOSED: 4.0U, 4.0U, 4.0U, 4.0U AND 16.0U. ALL DOSED VALUES DISPLAY IN THE APP AS FOLLOW, 4.0U, 2.0U, 2.5U, 3.5U AND 8.5U. MOST VALUES DOSED WERE DISPLAYED INACCURATELY IN THE LOGBOOK. ALL DOSES WERE WRITTEN TO THE APP LOGBOOK WITHIN 1 MINUTE. THE SCREW WAS NOT BENT, ADVANCED WHEN DOSAGE KNOB WAS PRESSED DIALING A DOSAGE AND RETRACTED APPROPRIATELY. NO RESISTANCE WAS OBSERVED WHEN DOSING WITHOUT A CARTRIDGE INSTALLED. THE SCREW ADVANCED EVERY TIME 30.0U WAS DIALED AND DOSED UNTIL THE SCREW REACHED MAX EXTENSION. IN CONCLUSION: INPEN DID PRODUCE FALSE DOSE LOGS DURING INVESTIGATION. THE CUSTOMER COMPLAINT OF DOSE LOG ANOMALIES WAS CONFIRMED. INPEN WILL BE SENT TO S.D LOCATION FOR FURTHER INVESTIGATION. MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY "DEFECTS" OR HAS "MALFUNCTIONED". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT.
CURRENTLY IT IS UNKNOWN WHETHER OR NOT THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT AS NO PRODUCT HAS BEEN RETURNED. THE DEVICE WILL BE RETURNED FOR ANALYSIS AND FURTHER INFORMATION WILL FOLLOW ONCE THE ANALYSIS HAS BEEN COMPLETED. NO CONCLUSION CAN BE DRAWN AT THIS TIME.
INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PEN HAD DOSE LOG INACCURACY. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PEN WILL BE RETURNED FOR ANALYSIS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1804465 | INPEN MMT-105NNPKNA NOVO NORDISK PINK | SYRINGE, PISTON | FMF | COMPANION MEDICAL INC | MMT-105NNPKNA | B94KE | 000010862088000368 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 21 YR | Unknown |